BioTech IP Review

ATF6 Inhibitors and Uses Thereof

Patent Title: ATF6 inhibitors and uses thereof
Priority Filing Date: April 6, 2019
Published As: US 10829485 B2
Assigned to: Later assigned to Altos Labs, Inc. (via assignment from Praxis Biotech LLC)

What This Patent Covers

This patent family discloses:

Compounds that inhibit ATF6
  • ATF6 (Activating Transcription Factor 6) is a protein involved in the cellular endoplasmic reticulum (ER) stress response — a pathway cells use when they accumulate misfolded proteins.
  • Specific small-molecule inhibitors are claimed that interact with ATF6 and can modulate this stress response.
Therapeutic uses
  • The compounds are proposed for treating diseases or disorders mediated by ATF6, including:
    • Neurodegenerative diseases
    • Vascular conditions
    • Certain cancers
    • Inflammatory or stress-associated pathologies
  • By reducing harmful chronic ER stress, the invention aims to improve cellular resilience and health.

Why This Patent Is Important

1. First Patent in Altos Labs’ Portfolio

According to IP records, this ATF6 inhibitor invention is the earliest patent that Altos Labs ultimately added to its portfolio — marking the company’s foundational therapeutic IP.

2. Broad Therapeutic Potential

ER stress and ATF6 activation are implicated in aging and major diseases (neurodegeneration, metabolic dysfunction, cardiovascular stress) — areas with huge unmet medical need and large markets. Modulating ATF6 could have benefits across these domains.

3. Portfolio Value and Licensing

Owning chemical scaffolds and claimed uses for inhibitors of a key cellular regulator enhances Altos Labs’ ability to partner with pharma, license technology, or develop drug candidates targeting age-related or chronic diseases.

4. Longevity & Cellular Health Relevance

Although Altos Labs is best known for cell rejuvenation research, this patent underscores a complementary strategy: modulating stress response pathways to improve cell resilience — a mechanism aligned with durability and healthspan therapies.

Summary

  • Patent: ATF6 inhibitors and uses thereof
  • Focus: Chemical compounds targeting the ATF6 stress response pathway and their therapeutic applications.
  • Strategic Importance: Acts as one of Altos Labs’ earliest and broad-scope patent assets with potential therapeutic and licensing value across major age-related diseases.

Leave a comment